These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 27578463)

  • 21. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges.
    Williams AN; Simon RA; Woessner KM; Stevenson DD
    J Allergy Clin Immunol; 2007 Aug; 120(2):273-7. PubMed ID: 17481713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history and clinical features of aspirin-exacerbated respiratory disease.
    Fahrenholz JM
    Clin Rev Allergy Immunol; 2003 Apr; 24(2):113-24. PubMed ID: 12668892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omalizumab in patient with aspirin exacerbated respiratory disease and chronic idiopathic urticaria.
    Porcaro F; Di Marco A; Cutrera R
    Pediatr Pulmonol; 2017 May; 52(5):E26-E28. PubMed ID: 27685608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Samter's Triad to Aspirin-Exacerbated Respiratory Disease: Historical Perspective and Current Clinical Practice.
    Krouse HJ; Krouse JH
    ORL Head Neck Nurs; 2015; 33(4):14-8. PubMed ID: 26753248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity.
    Morales DR; Guthrie B; Lipworth BJ; Jackson C; Donnan PT; Santiago VH
    Allergy; 2015 Jul; 70(7):828-35. PubMed ID: 25855099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis.
    Dursun AB; Woessner KA; Simon RA; Karasoy D; Stevenson DD
    Ann Allergy Asthma Immunol; 2008 May; 100(5):420-5. PubMed ID: 18517072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
    Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
    J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
    Tyrak KE; Kupryś-Lipińska I; Czarnobilska E; Jakieła B; Pajdzik K; Ćmiel A; Plutecka H; Koziej M; Gawrońska A; Konduracka E; Kuna P; Sanak M; Mastalerz L
    Respir Med; 2019 Jun; 152():51-59. PubMed ID: 31128610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety, Outcomes, and Recommendations for Two-Step Outpatient Nonsteroidal Anti-Inflammatory Drug Challenges.
    Li L; Bensko J; Buchheit K; Saff RR; Laidlaw TM
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1286-1292.e2. PubMed ID: 34800703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease.
    Chen JR; Buchmiller BL; Khan DA
    J Allergy Clin Immunol Pract; 2015; 3(6):926-31.e1. PubMed ID: 26282158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
    Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
    J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Asthma exacerbation due to preoperative NSAID use].
    Miry T; van der Sar-van der Brugge S; van der Rijt AJM
    Ned Tijdschr Geneeskd; 2021 Mar; 165():. PubMed ID: 33720565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
    Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
    Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Updates in Understanding NSAID Hypersensitivity.
    Minaldi E; Cahill K
    Curr Allergy Asthma Rep; 2023 Mar; 23(3):181-188. PubMed ID: 36757490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anosmia and an uncommon nonsteroidal anti-inflammatory drug reaction in a 38-year-old man.
    Speck AL; Baldwin JL
    Allergy Asthma Proc; 2013; 34(3):292-6. PubMed ID: 23676579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a multicenter randomized control crossover trial.
    Sommer DD; Rotenberg BW; Sowerby LJ; Lee JM; Janjua A; Witterick IJ; Monteiro E; Gupta MK; Au M; Nayan S
    Int Forum Allergy Rhinol; 2016 Apr; 6(4):385-91. PubMed ID: 26751262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypersensitivity to dipyrone in aspirin-exacerbated respiratory disease patients is associated with urticaria.
    Agondi RC; Dias GMFS; Assis JP; Pacheco R; Kalil J; Giavina-Bianchi P
    Respir Med; 2020; 170():106041. PubMed ID: 32843172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of LTRA in L-ASA Challenge for Aspirin-Exacerbated Respiratory Disease Diagnosis.
    Ramírez-Jiménez F; Vázquez-Corona A; Sánchez-de la Vega Reynoso P; Pavón-Romero GF; Jiménez-Chobillon MA; Castorena-Maldonado AR; Teran LM
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1554-1561. PubMed ID: 33160093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.